A new target against addiction
Nature Medicine
August 23, 2010
Inhibiting the enzyme aldehyde dehydrogenase-2 (ALDH-2) ― a natural enzyme in the body ― may have therapeutic potential against cocaine addiction, according to an article in this week's Nature Medicine.
Despite many studies of the neurobiology of drug addiction, there is no effective treatment for cocaine addiction. ALDH-2 is known to reduce the level of acetaldehyde, a molecule that accumulates after alcohol abuse to trigger the symptoms of a hangover. Lina Yao and her colleagues show that an inhibitor of ALDH-2 prevents rats from self-administering cocaine. The inhibitor acts by indirectly decreasing the production and release of dopamine, a molecule critical for the rewarding effects of cocaine and other drugs.
Crucially, the inhibitor not only prevented cocaine self-administration, but also relapse ― the return to the addictive state after a period of improvement. As relapse is often a health problem as serious as the original addiction, the therapeutic potential of ALDH-2 inhibitors warrants serious consideration.
doi: 10.1038/nm.2200
Research highlights
-
Aug 12
Ageing: Mutations in the ageing human heart identifiedNature Aging
-
Aug 12
Palaeontology: T. rex and relatives traded big eyes for bigger bitesCommunications Biology
-
Aug 10
Epidemiology: Estimating the risk of SARS-related coronaviruses from bats in Southeast AsiaNature Communications
-
Aug 5
Microbiology: Single switch makes Escherichia coli beneficial insect partnerNature Microbiology
-
Aug 5
Conservation: More than half of unassessable species may be at risk of extinctionCommunications Biology
-
Aug 4
Physiology: Restoring cellular functions in pigs after deathNature